HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different

被引：0
|
作者：
Mon, Khin Su [1 ]
Zhang, Hui [1 ]
Aragao, Alessa [2 ]
Tang, Ping [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
193
引用
收藏
页码：S182 / S183
页数：2
相关论文
共 50 条
  • [11] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [12] HER2 Intermediate Breast Cancers
    Jensen, Kristin C.
    Nielsen, Torsten O.
    Gilks, C. Blake
    West, Robert B.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (11) : 1739 - 1739
  • [13] Fluorescence in situ hybridization (FISH) results in HER2 score 1+and 2+breast cancers
    Tamura, Gen
    Suzuki, Yoshio
    PATHOLOGY INTERNATIONAL, 2016, 66 (02) : 118 - 119
  • [14] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [15] Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation. 8067
    Li, Bob T.
    Ross, Dara S.
    Chaft, Jamie E.
    Hsu, Meier
    Kako, Severine
    Aisner, Dara L.
    Kris, Mark G.
    Varella-Garcia, Marileila
    Arcila, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [16] Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?
    Wang, Minhua
    Ding, Qingqing
    Gu, Jun
    Sfamenos, Steven M.
    Huo, Lei
    Tang, Zhenya
    Sun, Hongxia
    Robinson, Melissa
    Tang, Guilin
    Lim, Bora
    Wu, Yun
    Albarracin, Constance T.
    Sahin, Aysegul A.
    Chen, Hui
    CLINICAL BREAST CANCER, 2023, 23 (04) : 415 - 422
  • [17] HER2 Testing by FISH: Discordance between HER2 Signals Per Cell and HER2:CEP 17 Ratio
    Dintzis, S. M.
    Allison, K. H.
    Schmidt, R. A.
    CANCER RESEARCH, 2010, 70
  • [18] Quantitative measurements of HER2 expression and HER2: HER2 dimerization identify subgroups of HER2 positive metastatic breast cancer patients with different probabilities of response to trastuzumab treatment
    Huang, W.
    Lipton, A.
    Leitzel, K.
    Ali, S. M.
    Fuchs, E. M.
    Weidler, J.
    Chappey, C.
    Sperinde, J.
    Tan, Y.
    Jin, X.
    Paquet, A.
    Winston, J.
    Petropoulos, C.
    Kostler, W. J.
    Bates, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S86 - S86
  • [19] HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results
    Li, Zaibo
    Hou, Yanjun
    Nitta, Hiroaki
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [20] Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
    Ardor, Gokce Deniz
    Komforti, Miglena K.
    Hanna, Helena
    Ibanoglu, Onur
    Lochala, Abigail
    Nassar, Aziza
    BREAST JOURNAL, 2023, 2023
12345